First Medical & Healthcare LP-GP Networking Event: Bridging Capital and Opportunities

The winter of the capital market seems not to have passed yet,In 2023, fundraising challenges continued to plague general partners (GPs) in the healthcare and life sciences industry; meanwhile, limited partners (LPs) were uncertain about where to deploy their capital. On one side were GPs lacking funding, and on the other were LPs with abundant resources. Despite this seemingly complementary supply-and-demand dynamic, neither party’s needs were adequately met. Given the divergent specific requirements and investment directions, successfully matching suitable GPs with LPs proved to be no easy task.

Fundraising difficulties, at their core, stem fromLPs and GPs lack a platform for in-depth engagement and dialogue. To address this communication challenge, starting in August 2023, VCBeat Select will collaborate with renowned regional LPs and GPs across China to launch the “LP-GP Matchmaking Series” for healthcare funds. This initiative will facilitate targeted, multi-tiered, and precise matchmaking between LPs and GPs, ensuring that capital held by LPs is allocated to suitable GPs with high quality and efficiency.

Against this backdrop, VCBeat, in collaboration with the management entity of the Shanghai Angel Investment Guidance Fund, willOn Thursday, August 24, the 2023 Inaugural LP & GP Matchmaking Event will be held at Shanghai Venture Relay in Shanghai. High-quality LPs and seasoned GPs are cordially invited to participate!

Event Duration:Thursday, August 24, 2023, 14:00

Event Venue: Shanghai Chuangye JieLi Group

Event Format: Offline Closed-Door Meeting+Banquet

Target Audience: China's Healthcare IndustryGP

1. Intention to establish a fund in Shanghai;

2. Have focused on or previously invested in early-stage healthcare projects;

3. Eligible applicants are partners of investment institutions.

Shanghai Chuangye Jieli Sci-Tech Finance Group Co., Ltd. (hereinafter referred to as“Chuangye JieLi Group”) was established in 2010 with a registered capital of RMB 255 million. With the mission of “Focusing on Tech Startups, Supporting Enterprise Growth,” Chuangye JieLi Group has built an early-stage sci-tech enterprise service ecosystem centered around three core businesses: fund management, financial services, and sci-tech innovation services. The group manages funds exceeding RMB 6 billion, provides debt financing services totaling over RMB 22 billion, has directly or indirectly invested in more than 1,000 early-stage startups, and served over 10,000 sci-tech enterprises.

VCBeat, founded in 2014 and affiliated with Beijing Danhuang Technology Co., Ltd., is a leading research and media platform for China’s healthcare industry. It continuously tracks and studies the transformation of the healthcare sector amid global technological shifts, conducting research and reporting on the policies, capital, enterprises, and key figures that drive industrial development. Its core user base includes company founders and business leaders, industry investors, and policy researchers.

[VBSelect] is a service under VCBeat that focuses on integrating brand building with performance-driven marketing and conversion. It features columns and activities such as [Open Courses], [New Product Reviews], and [Government-Enterprise Forums]. Backed by VCBeatA reachable audience of 300,000 professionals in the innovative healthcare sector. Through rigorous topic and product selection, coupled with professional content planning and precise, effective outreach, we help enterprises efficiently, accurately, and rapidly promote innovative products and services. This approach not only enhances brand visibility but also precisely reaches target potential partners.

Scan the QR code below to contact the assistant for registration.